Cyclophosphamide

Biopsy-proven, Positive Lymph Node(s)

Laura M. Spring, MDSmall moleculePhase 3Active

BB

66/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 52/ 100
Competitive Position: 95/ 100

Competitive context

15 Active assets in the Biopsy-proven, Positive Lymph Node(s) cohort.

Asset / Sponsor	Phase	Rating
Inno-206 Laura M. Spring, MD	Phase 3	BB
Indocyanine Green Isabelle Henskens	Phase 4	BB
TAMOXIFEN National Cancer Institute (NCI)	Phase 3	BB
Inno-206 National Cancer Institute (NCI)	Phase 3	BB
Cyclophosphamide National Cancer Institute (NCI)	Phase 3	B

View all 24 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant

BBB

Indicative ·

79 / 100

mycosis fungoidesDormant

BBB

Indicative ·

78 / 100

B-cell childhood acute lymphoblastic leukemiaDormant

BBB

Indicative ·

78 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.